Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human metapneumovirus (hMPV) fusion (F) protein is a class I viral fusion glycoprotein that is essential for the virus to enter host cells by mediating the fusion of the viral envelope with the host cell membrane. It exists in two primary conformations: a metastable prefusion state and a stable postfusion state. The prefusion-stabilized form is a critical target for vaccine development and therapeutic antibodies because it displays the most potent neutralizing epitopes, which are often lost during the transition to the postfusion state. By targeting the prefusion F protein, drugs and vaccines aim to elicit or provide antibodies that block the conformational change or sterically hinder membrane fusion, thereby preventing infection. This target is particularly relevant for protecting vulnerable populations, such as infants, the elderly, and the immunocompromised, from severe respiratory tract infections like bronchiolitis and pneumonia.
Neutralization of viral infection by binding to the prefusion conformation of the F protein, thereby preventing the structural transition to the postfusion state required for membrane fusion and viral entry into host cells.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human metapneumovirus fusion protein (hMPV F).